Elixir Pharmaceuticals Company
Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company's scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.
Founded Date:
1999-01-01
Total Funding:
$98.5M
Investor Type:
Company
Employee Number:
11-50
Funding Status:
Late Stage Venture
Number Of Exists:
Series D
Technology:
Geroscience
Last Funding Type:
Series D
Investors Number:
9
Industry:
Others
Headquarters:
United States
Estimated Revenue:
Less than $1M